The trial involved 80 women aged 45 and older with breast cancer who were about to start neoadjuvant chemotherapy (NCT), a type of chemo drug given before surgery to shrink tumors. Participants were randomly assigned to receive either 2,000 IU of vitamin D daily or a placebo for six months during their chemotherapy treatment.
